Discovery and Validation of Cell-Surface Protein Mesothelin (MSLN) As a Novel Therapeutic Target in AML: Results from the COG/NCI Target AML Initiative by Tarlock, Katherine, Kaeding, Allison J., Alonzo, Todd A., Loken, Michael R., Ries, Rhonda E., Pardo, Laura, Gerbing, Robert, Farrar, Jason E, Guidry Auvil, Jaime M., Gerhard, Daniela S., Smith, Malcolm A., Davidsen, Tanja M., Gesuwan, Pattee, Hermida, Leandro C., Marra, Marco A., Mungall, Andrew J., Mungall, Karen, Ma, Yussanne, Zong, Stuart, Long, William, Gamis, Alan S., Kolb, E. Anders, Meshinchi, Soheil

Get full text